Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy

被引:18
|
作者
Grootjans, Willem [1 ,2 ]
Usmanij, Edwin A. [1 ]
Oyen, Wim J. G. [1 ,3 ,4 ]
van der Heijden, Erik H. F. M. [5 ]
Visser, Eric P. [1 ]
Visvikis, Dimitris [6 ]
Hatt, Mathieu [6 ]
Bussink, Johan [7 ]
de Geus-Oei, Lioe-Fee [1 ,2 ,8 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiol, POB 9600, NL-2300 RC Leiden, Netherlands
[3] Inst Canc Res, London, England
[4] Royal Marsden NHS Fdn Trust, London, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Med, Nijmegen, Netherlands
[6] INSERM, UMR 1101, Lab Traitement Informat Med LaTIM, Brest, France
[7] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands
[8] Univ Twente, MIRA Inst, Biomed Photon Imaging Grp, Enschede, Netherlands
关键词
Early response monitoring; Non-small cell lung cancer; Concomitant chemoradiochemotherapy; F-18-FDG PET/CT; Total lesion glycolysis; Automatic image segmentation; TARGET VOLUME DELINEATION; RADIOTHERAPY FDG-PET; F-18-FDG PET; PROGNOSTIC VALUE; DOSE-ESCALATION; SURVIVAL; FAILURE; IMPACT; NSCLC; AREAS;
D O I
10.1016/j.radonc.2016.04.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study evaluated the use of total lesion glycolysis (TLG) determined by different automatic segmentation algorithms, for early response monitoring in non-small cell lung cancer (NSCLC) patients during concomitant chemoradiotherapy. Materials and methods: Twenty-seven patients with locally advanced NSCLC treated with concomitant chemoradiotherapy underwent F-18-fluorodeoxyglucose (FDG) PET/CT imaging before and in the second week of treatment. Segmentation of the primary tumours and lymph nodes was performed using fixed threshold segmentation at (i) 40% SUVmax (T40), (ii) 50% SUVmax (T50), (iii) relative-threshold-level (RTL), (iv) signal-to-background ratio (SBR), and (v) fuzzy locally adaptive Bayesian (FLAB) segmentation. Association of primary tumour TLG (TLGT), lymph node TLG (TLGLN), summed TLG (TLG(S) = TLG(T) + TLG(LN)), and relative TLG decrease (Delta TLG) with overall -survival (OS) and progression-free survival (PFS) was determined using univariate Cox regression models. Results: Pretreatment TLG(T) was predictive for PFS and OS, irrespective of the segmentation method used. Inclusion of TLG(LN) improved disease and early response assessment, with pretreatment TLG(S) more strongly associated with PFS and OS than TLG(T) for all segmentation algorithms. This was also the case for Delta TLG(S), which was significantly associated with PFS and OS, with the exception of RTL and T40. Conclusions: Delta TLG(S) was significantly associated with PFS and OS, except for RTL and T40. Inclusion of TLG(LN) improves early treatment response monitoring during concomitant chemoradiotherapy with FDG-PET. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:473 / 479
页数:13
相关论文
共 50 条
  • [31] Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
    Dugage, Matthieu Roulleaux
    Albarran-Artahona, Victor
    Laguna, Juan Carlos
    Chaput, Nathalie
    Vignot, Stephane
    Besse, Benjamin
    Mezquita, Laura
    Auclin, Edouard
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 179 - 196
  • [32] Weight loss predicts poor prognosis in patients treated with concurrent chemoradiotherapy for stage III non-small cell lung cancer
    Wei, Min
    Xie, Conghua
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (14): : 6308 - 6313
  • [33] Stereotactic ablative radiotherapy after concomitant chemoradiotherapy in non-small cell lung cancer: A TITE-CRM phase 1 trial
    Doyen, Jerome
    Poudenx, Michel
    Gal, Jocelyn
    Otto, Josiane
    Guerder, Caroline
    Naghavi, Arash O.
    Gerard, Anais
    Leysalle, Axel
    Cohen, Charlotte
    Padovani, Bernard
    Ianessi, Antoine
    Schiappa, Renaud
    Chamorey, Emmanuel
    Bondiau, Pierre-Yves
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (02) : 239 - 245
  • [34] Predictive value of tumor volume change during chemoradiotherapy in non-small cell lung cancer
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Song, Si Yeol
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1641 - S1642
  • [35] Flare Response versus Disease Progression in Patients with Non-small Cell Lung Cancer
    Al-Nabhani, Khalsa
    Syed, Rizwan
    Haroon, Athar
    Almukhailed, Omar
    Bomanji, Jamshed
    JOURNAL OF RADIOLOGY CASE REPORTS, 2012, 6 (11): : 34 - 42
  • [36] The study of the correlation between quantitative 18F-FDG PET/CT metabolic parameters and the early treatment response for non-small cell lung cancer with chemoradiotherapy
    Deng, Hongbin
    Ma, Changsheng
    Duan, Jinghao
    Luo, Judong
    Yin, Yong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (02): : 1133 - 1140
  • [37] Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer
    Dong, Xinzhe
    Sun, Xiaorong
    Sun, Lu
    Maxim, Peter G.
    Xing, Lei
    Huang, Yong
    Li, Wenwu
    Wan, Honglin
    Zhao, Xianguang
    Xing, Ligang
    Yu, Jinming
    PLOS ONE, 2016, 11 (06):
  • [38] Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer
    Kishida, Yukiko
    Hirose, Takashi
    Shirai, Takao
    Sugiyama, Tomohide
    Kusumoto, Soujiro
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Adachi, Mitsuru
    Nakamura, Akihiro
    ONCOLOGY LETTERS, 2011, 2 (05) : 949 - 955
  • [39] Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy
    Wada, Kentaro
    Kishi, Noriko
    Kanayama, Naoyuki
    Hirata, Takero
    Ueda, Yoshihiro
    Kawaguchi, Yoshifumi
    Morimoto, Masahiro
    Konishi, Koji
    Imamura, Fumio
    Ogawa, Kazuhiko
    Teshima, Teruki
    ANTICANCER RESEARCH, 2019, 39 (01) : 491 - 497
  • [40] Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer
    Uemura, Takehiro
    Fukumitsu, Kensuke
    Maeno, Ken
    Fukuda, Satoshi
    Onuki, Tomohiro
    Kanemitsu, Yoshihiro
    Oguri, Tetsuya
    Niimi, Akio
    Hida, Toyoaki
    RESPIROLOGY CASE REPORTS, 2021, 9 (09):